Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice

This study has been terminated.

( Lack of enrollment )

Study NCT00291057 Information provided by Taro Pharmaceuticals USA

First Received: February 10, 2006 Last Updated: May 4, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	December 2006
Primary Completion Date:	October 2006 (Final data collection date for primary outcome measure)